Q-linea AB (OSTO:QLINEA) Beta: 2.6298 (As of Jun. 28, 2026)


OSTO:QLINEA Q-linea AB OSTO:QLINEA
67 GF Score
Price kr18.10
GF Value kr19.86
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Q-linea AB Beta?

Q-linea AB OSTO:QLINEA +0.84% 67 Beta is 2.6298 as of Jun. 28, 2026. GuruFocus rates OSTO:QLINEA with a GF Score™ of 67/100 and a GF Value™ of kr19.86 (Fairly Valued). The stock has 3 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-28), Q-linea AB's Beta is 2.6298.


Q-linea AB  (OSTO:QLINEA) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Q-linea AB Beta Related Terms


Q-linea AB Beta Historical Data

* Premium members only.

The historical data trend for Q-linea AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-linea AB Beta Chart

Q-linea AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 1.05 0.18 -0.44 3.92

Q-linea AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.94 2.27 2.40 3.92 2.89

OSTO:QLINEA vs ABT, SYK, MDT: Beta Comparison

For the Medical Devices subindustry, Q-linea AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Q-linea AB Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Q-linea AB's Beta distribution charts can be found below:

* The bar in red indicates where Q-linea AB's Beta falls into.


OSTO:QLINEA
67GF Score
Q-linea AB OSTO:QLINEA
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-linea AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 2.6298 mean?
Q-linea AB (OSTO:QLINEA) has a Beta of 2.6298 as of Jun. 28, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Q-linea AB and its competitors.
Is Q-linea AB's Beta too high?
Q-linea AB's current Beta is 2.6298. Overall, Q-linea AB has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Q-linea AB's Beta compare to ABT and SYK?
Q-linea AB's Beta of 2.6298 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Q-linea AB and its competitors. Q-linea AB's current Beta is 2.6298. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-linea AB stock overvalued right now?
Based on GuruFocus' analysis, Q-linea AB (OSTO:QLINEA) is currently considered Fairly Valued. The stock's GF Value™ is kr19.86, compared to a current price of kr18.10 — trading 8.9% below its estimated fair value. The current Beta is 2.6298. Q-linea AB's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Q-linea AB (OSTO:QLINEA), the current Beta is 2.6298 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Q-linea AB (OSTO:QLINEA) Overvalued in 2026?

Based on GuruFocus' analysis, Q-linea AB stock appears to be undervalued. The current stock price of kr18.10 is trading 8.9% below its estimated GF Value™ of kr19.86. GuruFocus considers Q-linea AB to be Fairly Valued.

Key valuation signals for OSTO:QLINEA:

  • Beta: 2.6298
  • GF Value™: kr19.86 vs. price of kr18.10 (8.9% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the OSTO:QLINEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Q-linea AB Business Description

Other Exchanges 3F80:Germany
Address Dag Hammarskjolds vag 52 A, Uppsala, SWE, SE-752 37
Q-linea AB is a company that develops infection diagnostics solutions that benefit patients, healthcare providers, and society, enabling rapid diagnosis of blood infections such as sepsis within six hours of a positive blood culture. It focuses on developing instruments and consumables that benefit patients, healthcare providers, and society. It develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company's product, ASTar, is a fully automated instrument (AST, antibiotic susceptibility testing), which produces a sensitivity profile from a positive blood culture.
67GF Score

Get the complete analysis for OSTO:QLINEA

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr18.10
Price
kr19.86
GF Value